Overview
Carrie-Anne Ridsdale (Carrie), who presents publicly as Jayne Price claimed their shops carry and staff administer naloxone to reverse overdoses, but some statements about its effects and use are medically inaccurate and potentially dangerous.
Early in 2024, Carrie publicly stated that their shops would carry naloxone, describing it as a rescue medication for overdoses involving drugs and alcohol. They claimed staff would be trained to administer it, including through clothing using a nasal spray, and instructed that ambulances should be informed when naloxone is given. Carrie asserted that naloxone blocks drugs, alcohol, and opioids for up to 20 minutes and can save lives, and encouraged immediate provision to anyone requesting it urgently. These early claims reflect a basic understanding of naloxone's role in opioid overdose reversal but include inaccuracies regarding its effect on alcohol and the duration of action.
By early 2026, Carrie admitted to administering naloxone to a grandmother under the influence who was buying toys for a child, describing naloxone as life-saving and reversing certain opioids and drugs. They also expressed concern for the safety of the child and made a referral to the police. Carrie-Anne Ridsdale mentioned assisting a pregnant under-18 young woman and making a referral due to safeguarding concerns. These admissions indicate active involvement in naloxone distribution and some awareness of safeguarding responsibilities.
Later in early 2026, Carrie claimed they still stocked naloxone in their shops but denied currently giving it out directly, stating that distribution was through stockists. They also asserted having received training to administer naloxone. However, a whistleblower reported observing medical-style procedures conducted in non-clinical conditions linked to claims of nursing experience, raising concerns about Carrie's clinical competence and safety practices. Additionally, an incident was recounted where Carrie was under the influence of painkillers and morphine while responsible for premises, highlighting potential risks to vulnerable individuals.
Carrie-Anne Ridsdale's claim that naloxone blocks alcohol effects is medically incorrect; naloxone specifically reverses opioid overdoses and has no effect on alcohol intoxication. The assertion that naloxone blocks drugs for up to 20 minutes oversimplifies its pharmacology and may mislead about the need for urgent medical follow-up. The encouragement to provide naloxone immediately upon request without proper assessment or training could lead to misuse or delay in emergency response. The whistleblower's observations and Carrie's own admission of being under the influence while managing premises further compound safety concerns.
Overall, while Carrie demonstrates some knowledge of naloxone's life-saving potential in opioid overdoses and has engaged in distribution and referrals, their clinical claims contain inaccuracies that could endanger users. The reported unsafe practices and lack of formal clinical oversight amplify these risks. The case highlights the importance of accurate medical information and proper training when handling emergency medications like naloxone, especially in community settings without professional healthcare supervision.